Analyst Price Target is GBX 56.25
▲ +36.33% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Assura in the last 3 months. The average price target is GBX 56.25, with a high forecast of GBX 65 and a low forecast of GBX 51. The average price target represents a 36.33% upside from the last price of GBX 41.26.
Current Consensus is
The current consensus among 5 polled investment analysts is to moderate buy stock in Assura. This Moderate Buy consensus rating has held steady for over two years.
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion. At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.